In a significant move for the global healthtech sector, the Indian digital healthcare platform Practo has successfully expanded its operations to the United States market. This strategic expansion follows the company's earlier debut in the United Arab Emirates, marking a key step in its international growth strategy.
Rapid Organic Growth in a Competitive Market
Since officially entering the competitive US healthcare landscape in April 2025, Practo has demonstrated remarkable traction. The platform has managed to list profiles of more than 200,000 doctors across various specialties, indicating strong initial adoption by healthcare providers. This growth has been primarily organic, showcasing the platform's inherent value proposition for both doctors and patients seeking a streamlined appointment booking experience.
Financial Milestones and Market Impact
The operational success is mirrored in impressive financial metrics. Practo has reportedly reached an annualised Gross Merchandise Value (GMV) run-rate of over 75 million US dollars. This figure highlights the substantial transaction volume already flowing through the platform within a short span of time. The GMV run-rate is a crucial indicator of the scale and velocity of business on the platform, suggesting a promising start in one of the world's largest healthcare economies.
The expansion news was confirmed and reported by Uma Kannan, with the latest update published on 08 January 2026, at 06:43 IST. The company's headquarters in Bengaluru continues to drive its global ambitions, proving the capability of Indian-origin tech startups to scale and compete on an international stage.
Strategic Implications and Future Trajectory
Practo's successful foray into the US market, following its UAE launch, underscores a calculated global rollout plan. The ability to attract a vast network of doctors without heavy initial marketing spend points to a product-market fit that addresses clear gaps in healthcare accessibility and digitization. This move places Practo directly in competition with established US-based platforms, challenging the status quo with its experience from diverse markets like India.
The company's journey from a domestic Indian appointment-booking service to an international healthcare aggregator is a notable case study. It demonstrates how homegrown technology solutions, refined in a complex and high-volume market like India, can be effectively adapted for developed economies. The focus now will be on sustaining this growth, deepening engagement with the existing doctor network, and acquiring patients to complete the ecosystem loop.
